Meet Vium

Vium bridges the divide separating Silicon Valley innovation and preclinical drug research, where methodologies, systems, and tools have remained largely unchanged for decades.

Our team has developed the leading living informatics platform by incorporating core technology advancements in sensors, automation, and algorithms for processing big data.  Vium’s Digital Vivarium™ and Vium Cloud enable drug development researchers to make better decisions and conduct the highest quality studies in a fraction of the time compared with traditional methods.

We’re setting the standard for preclinical research by making drug development smarter and more efficient, and accelerating the process for bringing important breakthroughs to the people who need them.

Leadership

  • Wendel Barr, MBA

    Chief Executive Officer and Board Member

    Wendel has successfully led and driven long-term growth, operational excellence and expansion of major life sciences companies. Prior to joining Vium, Wendel was CEO and Board Member for SynteractHCR, leading the company through a transformative merger and growth phase to become a global leader in the mid-tier clinical research space. Previously, Wendel served as chief operating officer and executive vice president for Covance for the last three of his 10-year tenure with the company. In his first job at GE Healthcare, Wendel started as a field engineer then rose through the ranks into global leadership positions, including general manager. Wendel earned his B.S. in Electronics Engineering from DeVry Institute of Technology in Phoenix, Arizona and his MBA from National University in California.

  • Joe Betts-Lacroix

    Chief Technical Officer, Co-Founder, Board Member

    Joe was the primary technical founder of hardware/software startup OQO which entered the Guinness Book of World Records for building the smallest full-featured PC. His experience spans from biotech research to electronics design. Very experienced in invention, prosecution and monetization of intellectual property, he has over 80 Patents granted and pending in fields ranging from biophysics and safety systems to antennas, thermal systems, user interfaces and analog electronics. He has written numerous peer-reviewed publications in fields such as biophysics, genetics, electronics and robotics. Joe holds a Harvard A.B., MIT S.M. and Caltech research fellowship.

  • Tom Hoster, MBA

    Chief Financial Officer

    Tom is an accomplished CFO who has spent 25 of his 35-plus year career in Silicon Valley, building and leading technology and medical device companies through rapid growth and organizational change. His extensive experience in finance and administration includes fundraising in both private and public markets, US and international operations, financial modeling and metrics, and investor relations, as well as development and non-profit leadership. Prior to Vium, Tom served as the CFO for medical device startups eNeura and EndoGastric Solutions. Tom serves on the National Annual Giving Committee at Princeton University. He holds a BSE degree in Electrical Engineering from Princeton University and an MBA from Stanford University.

  • David Hutto, Ph.D., DVM, DACVP

    Chief Scientific Officer

    Dr. Hutto has extensive experience as a nonclinical pharmaceutical scientist and executive and has led key aspects of drug discovery and drug development leading in several cases to drug marketing approvals. Most recently David was at Charles River Laboratories as the Chief Scientific Officer of Safety Assessment, Veterinary Services and Animal Welfare and prior to that he was the Global Head of Drug Safety at Eisai, a biopharmaceutical company headquartered in Japan. David is a veterinarian with a PhD in immunology and specialty board certification in pathology and toxicology.

  • Larry Stevens

    VP Technology Operations

    Mr. Stevens has over 20 years of experience as an operations and development executive and has led multiple product launches and product ramps in emerging and multinational companies. Most recently Larry was at Robert Bosch Healthcare as the Vice President of Operations and Embedded Systems, where he was responsible for Global Operations and Hardware Development for Bosch’s medical device business unit. Prior to that, he was the Director of Manufacturing Operations at Curexo Technology Corporations and at several additional successful companies. Larry is certified in business management, portfolio, program and project management, and holds a Bachelor of Science in Technical Management and is a US Navy veteran.

  • Laura Schaevitz, Ph.D.

    VP of Scientific Technologies

    Laura Schaevitz has more than 15 years of experience with In vivo animal studies. As VP of Scientific Technologies at Vium, she oversees the development of animal models and draws upon her experiences as a molecular and behavioral neuroscientist to direct the application of Vium’s digital metrics to the animal models. In past experiences, Laura utilized a broad spectrum of mouse models including transgenic and nutrition-induced models of neurodevelopmental disorders such as autism, schizophrenia, Rett syndrome, and blindsight. Laura received her PhD in Neuroscience at Stanford University in 2006.

  • Daniel Ford, Ph.D.

    VP Software and Data Science

    Daniel Ford currently leads the Software and Data Science Division at Vium and is an expert in Data Science and Algorithms with over 20 years of experience in a wide range of applications. Dr. Ford earned his Phd from Stanford University in Mathematics applied to phylogenetics. Prior to Vium, he worked as Senior Statistician at Google, where he worked on topics ranging across search, global storage systems, social networks, down to memory allocators, and as VP of Software at Matterport, developing an end-to-end hardware-software system for creating, modifying, distributing, and navigating immersive 3D and virtual reality (VR) versions of real-world spaces. Dr. Ford’s other industry research and inventions range across applications including numerical algorithms, computational algebra, and simulations of electricity grids and markets.

  • Anna McKenzie

    Director of People

    Anna McKenzie has over 15 years of experience in people operations and believes that human capital is every organization’s greatest asset.  As the Director of People, Anna is responsible for implementing people management strategies that enable Vium to recruit, train, and retain a high performing and motivated workforce.  Prior to Vium, Anna served in various people leadership roles in which she was instrumental in developing and implementing on-boarding, training and development, performance management, benefits management and employee relations policies and strategies.  Anna holds a B.A. in Psychology from Le Moyne College and completed significant graduate coursework in Industrial Labor Relations at West Virginia University.  Anna is an identical twin and comes from a large and close family.  She participates in half marathons around the world and loves to dabble in cooking.

  • Abe Couse

    VP of Marketing

    Abe is responsible for product management and marketing at Vium. He has over 20 years of experience in the life sciences field and has held several product management, marketing and senior level business positions. He most recently served as VP of Life Science at Crown Bioscience overseeing new product development as well as product sales and marketing.  Prior to that he led the marketing and product groups at Epitomics and served in marketing and product management positions at Becton Dickinson and Clontech Laboratories.

Board Members

  • Wendel Barr, MBA

    Chief Executive Officer and Board Member

    Wendel has successfully led and driven long-term growth, operational excellence and expansion of major life sciences companies. Prior to joining Vium, Wendel was CEO and Board Member for SynteractHCR, leading the company through a transformative merger and growth phase to become a global leader in the mid-tier clinical research space. Previously, Wendel served as chief operating officer and executive vice president for Covance for the last three of his 10-year tenure with the company. In his first job at GE Healthcare, Wendel started as a field engineer then rose through the ranks into global leadership positions, including general manager. Wendel earned his B.S. in Electronics Engineering from DeVry Institute of Technology in Phoenix, Arizona and his MBA from National University in California.

  • Joe Betts-Lacroix

    Chief Technical Officer, Co-Founder, Board Member

    Joe was the primary technical founder of hardware/software startup OQO which entered the Guinness Book of World Records for building the smallest full-featured PC. His experience spans from biotech research to electronics design. Very experienced in invention, prosecution and monetization of intellectual property, he has over 80 Patents granted and pending in fields ranging from biophysics and safety systems to antennas, thermal systems, user interfaces and analog electronics. He has written numerous peer-reviewed publications in fields such as biophysics, genetics, electronics and robotics. Joe holds a Harvard A.B., MIT S.M. and Caltech research fellowship.

  • Dr. Annalisa Jenkins, MBBS, MRCP

    CEO, Dimension Therapeutics

    Dr. Jenkins has built and led teams advancing programs from scientific research through clinical development, regulatory approval and into healthcare systems globally. She is a member of the European Commission’s Scientific Panel for Health, a science-led expert group tasked with helping to achieve better health and wellbeing for all, and a committee member of the Science Board to the U.S. Food & Drug Administration, which advises FDA leadership on complex scientific and technical issues.

  • Jeff Kindler

    Former CEO, Pfizer

    Jeff is a partner at Lux Capital and senior advisor to Paragon Pharmaceuticals, a global investment firm that builds and manages innovative pharmaceutical companies. He serves on the boards of biotech companies, including PPD and Intrexon, and as a member of President Obama’s Management Advisory Board. Jeff formerly served as the Chairman and CEO of Pfizer, Chairman of PhRMA (Pharmaceutical Researchers and Manufacturers of America) and member of the board of the Federal Reserve Bank of New York.

  • Peter Hebert

    Co-Founder and Managing Partner, Lux Capital

    Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. His goal: to seek out founders developing things most people thought would not work, yet if they did, would become so intrinsic to our way of life that we would someday take them for granted.

    Today Lux supports a wide range of once-impossible-sounding advancements, including 3D printing and imaging, nuclear waste cleanup, machine learning and robots that fly or conduct microsurgery.

    Peter leads Lux’s investments in Accelergy; Auris Surgical Robotics; Everspin Technologies (NASDAQ: MRAM); Flex Logix; G2X Energy; Halo Neuroscience; Lux Research (acquired by Private Equity); Luxtera; Matterport; SiBEAM (NASDAQ: SIMG); Transphorm and Vium. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm.

    Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.

  • Zachary Bogue

    Managing Partner, Data Collective

    Zachary Bogue, co-Managing Partner of Data Collective, brings to bear over 15 years of experience in Silicon Valley as an entrepreneur, advisor, angel investor and attorney. At DCVC, Zack’s investment interests include next-generation space informatics platforms like Planet Labs, where he sits on the board, AI-enabled global risk mitigation systems like Metabiota, and disruptive financial services platforms using machine-learning to serve the unbanked more quickly and fairly, like LendUp and Tala.

    In 2015, the World Economic Forum recognized Zack’s leadership at the intersection of transformative technology and urgent global issues, and named Zack a Young Global Leader. He is active in the Davos community. As an angel investor, he has invested in startups like Square (SQ), Docker, AngelList and Uber. Zack is a co-founder and managing partner of Founders Den, a co-working space and community of experienced technology entrepreneurs.

    Previously, Zack co-founded and ran Montara Capital Partners, a real estate private equity fund, and he practiced law at Wilson Sonsini Goodrich & Rosati. Zack serves on the non-profit boards of the East Palo Alto Charter School and the Fine Arts Museums of San Francisco.

    Zack graduated with honors from Harvard University in Environmental Science and earned his JD with honors from Georgetown Law School, where he was executive editor for The Tax Lawyer.

  • Armen Vidian

    Operating Partner, Data Collective

    Armen brings the perspective of an entrepreneur and startup co-founder, a product marketer in Fortune 500 healthcare companies, and an investor to Data Collective (DCVC) as an Operating Partner. He leverages these diverse experiences to guide companies in the portfolio in their growth, focusing specifically on those in healthcare and biotech. Armen’s operational experience spans across medical devices, pharmaceuticals, insurance, and compute-driven startups in healthcare. Early in his career, he developed an online pharmacy for one of the first patient health record companies. He then spent several years in product management and early market development for first-in-class technologies at Guidant, Edwards Lifesciences, and Evalve (acquired by Abbott Laboratories).

    After Abbott, he co-founded DCVC company BlueTalon, which was initially focused on enterprise data security for data-driven clinical trial design and population health management. In addition to his operating role, Armen also leverages his unique cross-industry experience in technology and healthcare to identify new high potential startups for investment at the intersection of deep compute/Big Data and the life sciences. Armen holds an M.S. in Management Science from Stanford University and an S.B. in Biomechanical Engineering and a Minor in French from MIT.

Advisors

  • Timothy L. Robertson, Ph. D

    Co-Founder

    Tim co-founded Vium in 2013 and served as the company’s CEO until August 2017. As a physicist and serial entrepreneur, Tim’s vision for transforming the $10 billion preclinical drug development industry laid the foundation for Vium’s core technology, products, science, customer relationships, and team.

    He has more than 20 years of experience in all stages of technology start-up process, from invention and product development to commercialization and monetization. Prior to Vium, Tim was VP of Product Applications at Proteus Digital Health, responsible for management of alliances with global pharmaceutical companies, core technology coordination and software development. He is the holder of more than a dozen US patents and author of more than 40 scholarly publications in diverse fields. Tim has an A.B. in experimental physics and cosmology from Princeton University and Ph.D. in quantum physics from the University of California, Berkeley.

  • Scott J. Dylla, Ph.D.

    Chief Scientific Officer & Co-Founder at Stemcentrx

    Scott Dylla is the co-founder and Chief Scientific Officer of Stemcentrx, where he oversees research and development activities. Scott trained as a postdoctoral scholar at Stanford University in the laboratory of Dr. Irving L. Weissman, where he was awarded American Cancer Society and Stanford Immunology fellowships, and was subsequently a Sr. Scientist at OncoMed Pharmaceuticals. In 2005, Scott was recognized by the British Council as one of eight outstanding young US-based researchers in the field of stem cell biology.

  • Clifford Roberts, DVM DACLAM

    Former President, American College of Lab Animal Medicine

    Clifford Roberts, DVM, is the former President of the American College of Lab Animal Medicine (ACLAM) and currently serves as associate vice chancellor of the Laboratory Animal Resource Center (LARC) within the University of California San Francisco Office of Research. A diplomate of the American College of Laboratory Animal Medicine, Roberts is the recipient of numerous honors and awards, including the US Army Surgeon General’s “A” Designation in Laboratory Animal Medicine. He received his BS and DVM degrees from Texas A&M University. Roberts previously served as deputy director at the Walter Reed Army Institute of Research, and as director/commander of the US Army Medical Research Unit in Kenya.

  • David Sinclair, Ph.D.

    Professor of Genetics, Harvard Medical School

    David Sinclair, Ph.D. is Co-Director of the Paul F. Glenn Center for the Biology of Aging, a Professor of Genetics at Harvard Medical School, Associate Member of the Broad Institute for Systems Biology and co-founder of Sirtris Pharmaceuticals. Dr. Sinclair has received several prestigious awards including a Special Fellowship from the Leukemia Society, a Ludwig Scholarship and an American Association for Aging Research Fellowship. He’s also won the Genzyme Outstanding Achievement in Biomedical Science Award for 2004.

Let’s advance human health together.

We’re helping scientists and businesses bring important new treatments to market faster than ever.

We're always looking for smart, purpose-driven team members specializing in preclinical sciences and software engineering to build on our solution. Want to use your experience to help save lives?

Join the Team